Estimated glomerular filtration rate and proteinuria are associated with persistent form of atrial fibrillation: Analysis in Japanese patients

Journal of Cardiology

Volumn 61, Issue 1, 2013, Pages 53-57

  Suzuki, Shinya ^a   Sagara, Koichi ^a   Otsuka, Takayuki ^a   Kanou, Hiroto ^a   Matsuno, Shunsuke ^a   Uejima, Tokuhisa ^a   Oikawa, Yuji ^a   Koike, Akira ^a   Nagashima, Kazuyuki ^a   Kirigaya, Hajime ^a   Yajima, Junji ^a   Sawada, Hitoshi ^a   Aizawa, Tadanori ^a   Yamashita, Takeshi ^a  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

Author keywords

Atrial fibrillation; Renal function; Risk factors

Indexed keywords

ANTIARRHYTHMIC AGENT; CREATININE; DIGITALIS;

ADULT; ARTICLE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN TISSUE; JAPANESE; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL HEART ATRIUM FIBRILLATION; PERSISTENT HEART ATRIUM FIBRILLATION; PROGNOSIS; PROTEINURIA;

AGED; ATRIAL FIBRILLATION; ATRIAL FUNCTION, LEFT; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PROTEINURIA; STROKE VOLUME;

EID: 84872419298     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.07.016     Document Type: Article

References (49)

1. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., Singer D.E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285:2370-2375.
2. Kato T., Yamashita T., Sagara K., Iinuma H., Fu L.T. Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study. Circ J 2004, 68:568-572.
3. de Vos C.B., Pisters R., Nieuwlaat R., Prins M.H., Tieleman R.G., Coelen R.J., van den Heijkant A.C., Allessie M.A., Crijns H.J. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 2010, 55:725-731.
4. Tsang T.S., Barnes M.E., Miyasaka Y., Cha S.S., Bailey K.R., Verzosa G.C., Seward J.B., Gersh B.J. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J 2008, 29:2227-2233.
5. Iguchi Y., Kimura K., Kobayashi K., Aoki J., Terasawa Y., Sakai K., Uemura J., Shibazaki K. Relation of atrial fibrillation to glomerular filtration rate. Am J Cardiol 2008, 102:1056-1059.
6. McManus D.D., Corteville D.C., Shlipak M.G., Whooley M.A., Ix J.H. Relation of kidney function and albuminuria with atrial fibrillation (from the Heart and Soul Study). Am J Cardiol 2009, 104:1551-1555.
7. Alonso A., Lopez F.L., Matsushita K., Loehr L.R., Agarwal S.K., Chen L.Y., Soliman E.Z., Astor B.C., Coresh J. Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2011, 123:2946-2953.
8. Watanabe H., Watanabe T., Sasaki S., Nagai K., Roden D.M., Aizawa Y. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 2009, 158:629-636.
9. Sandhu R.K., Kurth T., Conen D., Cook N.R., Ridker P.M., Albert C.M. Relation of renal function to risk for incident atrial fibrillation in women. Am J Cardiol 2012, 109:538-542.
10. Horio T., Iwashima Y., Kamide K., Tokudome T., Yoshihara F., Nakamura S., Kawano Y. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients. J Hypertens 2010, 28:1738-1744.
11. Benjamin E.J., Levy D., Vaziri S.M., D'Agostino R.B., Belanger A.J., Wolf P.A. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994, 271:840-844.
12. Psaty B.M., Manolio T.A., Kuller L.H., Kronmal R.A., Cushman M., Fried L.P., White R., Furberg C.D., Rautaharju P.M. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997, 96:2455-2461.
13. Wang T.J., Parise H., Levy D., D'Agostino R.B., Wolf P.A., Vasan R.S., Benjamin E.J. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004, 292:2471-2477.
14. Thomas M.C., Dublin S., Kaplan R.C., Glazer N.L., Lumley T., Longstreth W.T., Smith N.L., Psaty B.M., Siscovick D.S., Heckbert S.R. Blood pressure control and risk of incident atrial fibrillation. Am J Hypertens 2008, 21:1111-1116.
15. Tsang T.S., Gersh B.J., Appleton C.P., Tajik A.J., Barnes M.E., Bailey K.R., Oh J.K., Leibson C., Montgomery S.C., Seward J.B. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002, 40:1636-1644.
16. Watanabe H., Tanabe N., Watanabe T., Darbar D., Roden D.M., Sasaki S., Aizawa Y. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata Preventive Medicine Study. Circulation 2008, 117:1255-1260.
17. Astor B.C., Hallan S.I., Miller E.R., Yeung E., Coresh J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol 2008, 167:1226-1234.
18. Sarnak M.J., Levey A.S. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000, 35:S117-S131.
19. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., McCullough P.A., Kasiske B.L., Kelepouris E., Klag M.J., Parfrey P., Pfeffer M., Raij L., Spinosa D.J., Wilson P.W., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003, 108:2154-2169.
20. Aviles R.J., Martin D.O., Apperson-Hansen C., Houghtaling P.L., Rautaharju P., Kronmal R.A., Tracy R.P., Van Wagoner D.R., Psaty B.M., Lauer M.S., Chung M.K. Inflammation as a risk factor for atrial fibrillation. Circulation 2003, 108:3006-3010.
21. Eustace J.A., Astor B., Muntner P.M., Ikizler T.A., Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 2004, 65:1031-1040.
22. Bailey G.W., Braniff B.A., Hancock E.W., Cohn K.E. Relation of left atrial pathology to atrial fibrillation in mitral valvular disease. Ann Intern Med 1968, 69:13-20.
23. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A., Bauer J.A., Tchou P.J., Niebauer M.J., Natale A., Van Wagoner D.R. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001, 104:2886-2891.
24. Suzuki S., Yamashita T., Otsuka T., Sagara K., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Ogasawara K., Sawada H., Aizawa T. Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004. Circ J 2008, 72:914-920.
25. Suzuki S., Yamashita T., Otsuka T., Sagara K., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Ogasawara K., Sawada H., Aizawa T. Recent mortality of Japanese patients with atrial fibrillation in an urban city of Tokyo. J Cardiol 2011, 58:116-123.
26. Suzuki S., Yamashita T., Ohtsuka T., Sagara K., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Ogasawara K., Sawada H., Yamazaki T., Aizawa T. Body size and atrial fibrillation in Japanese outpatients. Circ J 2010, 74:66-70.
27. Suzuki S., Sagara K., Otsuka T., Matsuno S., Funada R., Uejima T., Oikawa Y., Koike A., Nagashima K., Kirigaya H., Yajima J., Sawada H., Aizawa T., Yamashita T. Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. Circ J 2012, 76:607-611.
28. Nakamura M., Yamashita T., Yajima J., Oikawa Y., Ogasawara K., Kirigaya H., Sagara K., Koike A., Sawada H., Aizawa T. Impact of reduced renal function on prognosis in Japanese patients with coronary artery disease: a prospective cohort of Shinken Database 2007. Hypertens Res 2009, 32:920-926.
29. Nakamura M., Yamashita T., Yajima J., Oikawa Y., Ogasawara K., Sagara K., Koike A., Kirigaya H., Nagashima K., Otsuka T., Uejima T., Funada R., Matsuno S., Suzuki S., Sawada H., et al. Impact of early statin initiation on secondary prevention in Japanese patients with coronary artery disease. J Cardiol 2011, 57:172-180.
30. Nakamura M., Yamashita T., Yajima J., Oikawa Y., Ogasawara K., Sagara K., Kirigaya H., Koike A., Nagashima K., Ohtsuka T., Uejima T., Suzuki S., Sawada H., Aizawa T. Clinical outcome after acute coronary syndrome in Japanese patients: an observational cohort study. J Cardiol 2010, 55:69-76.
31. Goda A., Yamashita T., Suzuki S., Ohtsuka T., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Sagara K., Ogasawara K., Isobe M., Sawada H., Aizawa T. Prevalence and prognosis of patients with heart failure in Tokyo: a prospective cohort of Shinken Database 2004-5. Int Heart J 2009, 50:609-625.
32. Goda A., Yamashita T., Suzuki S., Ohtsuka T., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Sagara K., Ogasawara K., Isobe M., Sawada H., Aizawa T. Heart failure with preserved versus reduced left ventricular systolic function: a prospective cohort of Shinken Database 2004-2005. J Cardiol 2010, 55:108-116.
33. Kaneko H., Koike A., Senoo K., Tanaka S., Suzuki S., Nagayama O., Sagara K., Otsuka T., Matsuno S., Funada R., Uejima T., Oikawa Y., Yajima J., Nagashima K., Kirigaya H., et al. Role of cardiopulmonary dysfunction and left atrial remodeling in development of acute decompensated heart failure in chronic heart failure with preserved left ventricular ejection fraction. J Cardiol 2012, 59:359-365.
34. Senoo K., Suzuki S., Sagara K., Otsuka T., Matsuno S., Funada R., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Sawada H., Aizawa T., Yamashita T. Distribution of first-detected atrial fibrillation patients without structural heart diseases in symptom classifications. Circ J 2012, 76:1020-1023.
35. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., Yamagata K., Tomino Y., Yokoyama H., Hishida A. on behalf of the collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992.
36. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm A.J., Kirchhof P., Lip G.Y., Schotten U., Savelieva I., Ernst S., Van Gelder I.C., Al-Attar N., Hindricks G., Prendergast B., Heidbuchel H., Alfieri O., Angelini A., et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010, 31:2369-2429.
37. Allessie M., Ausma J., Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002, 54:230-246.
38. Kerr C.R., Humphries K.H., Talajic M., Klein G.J., Connolly S.J., Green M., Boone J., Sheldon R., Dorian P., Newman D. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J 2005, 149:489-496.
39. Parikh N.I., Hwang S.J., Larson M.G., Meigs J.B., Levy D., Fox C.S. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med 2006, 166:1884-1891.
40. Vaziri S.M., Larson M.G., Benjamin E.J., Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994, 89:724-730.
41. Chao T.F., Lin Y.J., Chang S.L., Lo L.W., Hu Y.F., Tuan T.C., Suenari K., Li C.H., Chen S.A. Associations between renal function, atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation. Circ J 2011, 75:2326-2332.
42. Siragy H.M., Carey R.M. Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. Am J Nephrol 2010, 31:541-550.
43. Li D., Shinagawa K., Pang L., Leung T.K., Cardin S., Wang Z., Nattel S. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001, 104:2608-2614.
44. Astor B.C., Coresh J., Heiss G., Pettitt D., Sarnak M.J. Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2006, 151:492-500.
45. Schlaich M.P., Socratous F., Hennebry S., Eikelis N., Lambert E.A., Straznicky N., Esler M.D., Lambert G.W. Sympathetic activation in chronic renal failure. J Am Soc Nephrol 2009, 20:933-939.
46. Schmidt M., Rieber J., Daccarett M., Marschang H., Sinha A.M., Biggar P., Jung P., Ketteler M., Brachmann J., Rittger H. Relation of recurrence of atrial fibrillation after successful cardioversion to renal function. Am J Cardiol 2010, 105:368-372.
47. Berkowitsch A., Kuniss M., Greiss H., Wójcik M., Zaltsberg S., Lehinant S., Erkapic D., Pajitnev D., Pitschner H.F., Hamm C.W., Neumann T. Impact of impaired renal function and metabolic syndrome on the recurrence of atrial fibrillation after catheter ablation: a long term follow-up. Pacing Clin Electrophysiol 2012, 35:532-543.
48. Tokuda M., Yamane T., Matsuo S., Ito K., Narui R., Hioki M., Tanigawa S., Nakane T., Yamashita S., Inada K., Shibayama K., Miyanaga S., Yoshida H., Miyazaki H., Date T., et al. Relationship between renal function and the risk of recurrent atrial fibrillation following catheter ablation. Heart 2011, 97:137-142.
49. Takahashi Y., Takahashi A., Kuwahara T., Okubo K., Fujino T., Takagi K., Nakashima E., Kamiishi T., Hikita H., Hirao K., Isobe M. Renal function after catheter ablation of atrial fibrillation. Circulation 2011, 124:2380-2387.